Literature DB >> 17395651

V2-antagonists for the treatment of hyponatraemia.

Guy Decaux1.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17395651     DOI： 10.1093/ndt/gfm136

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  4 in total

1.  Short-term efficacy and safety of vasopressin receptor antagonists for treatment of hyponatremia.

Authors:  Bertrand L Jaber; Leena Almarzouqi; Lea Borgi; Victor F Seabra; Ethan M Balk; Nicolaos E Madias
Journal:  Am J Med       Date:  2011-10       Impact factor: 4.965

Review 2.  Efficacy and Safety of Vasopressin Receptor Antagonists for Euvolemic or Hypervolemic Hyponatremia: A Meta-Analysis.

Authors:  Xiangyun Zhang; Mingyi Zhao; Wei Du; Dongni Zu; Yingwei Sun; Rongwu Xiang; Jingyu Yang
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

3.  Safety and Efficacy of Tolvaptan in Korean Patients with Hyponatremia Caused by the Syndrome of Inappropriate Antidiuretic Hormone.

Authors:  Sang Woong Han; Joo Hark Yi; Kyung Pyo Kang; Ha Yeon Kim; Soo Wan Kim; Hoon Young Choi; Sung Kyu Ha; Gheun Ho Kim; Yang Wook Kim; Kyung Hwan Jeong; Sug Kyun Shin; Ho Jung Kim
Journal:  J Korean Med Sci       Date:  2018-04-09       Impact factor: 2.153

4.  Estimated Daily Urine Volume and Solute Excretion from Spot Urine Samples to Guide the Therapy of Hyponatremia in SIADH.

Authors:  Guy Decaux; Wim Musch
Journal:  J Clin Med       Date:  2019-09-20       Impact factor: 4.241
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.